Implementation Supportive Framework Delphi Programme: Regional Expert Consensus on Health Technology Implementation
Innovationsinstitut für Gesundheit und Gesellschaft gUG
Objective
A two-round Delphi study generating peer-reviewed evidence on implementation-supportive factors across LATAM, Gulf/EMRO, and ASEAN.
InTRODUCTION
This programme invites regional experts to participate in a structured two-round Delphi study. The aim is to identify and prioritise the contextual factors that determine whether health technologies — starting with biosimilars as a first use case — are successfully implemented within health systems.
The study is part of the Implementation Supportive Framework (ISF) research programme, which is developing a decision-supportive architecture to guide the introduction of health technologies across different regional and system contexts.
How it works
Step 1: Round 1 survey
You complete an online questionnaire covering four domains: governance structures, financing flows, cultural acceptance and trust, and distributional context. Rating takes approximately 15-20 minutes. All responses are anonymous.
Contact information will be collected for Delphi Round #2 only.
Step 2: Feedback and Round 2 survey
You receive a summary of aggregated Round 1 results and are invited to revise your ratings in light of the group response. This iterative process generates regional consensus on implementation priorities.
Step 3: Regional publications
Participants who complete both rounds are invited to join the regional manuscripts as named co-authors. Three peer‑reviewed papers for LATAM, Gulf/EMRO, and ASEAN will be submitted to international scientific journals.
Step 4: Global in‑person workshop
Representatives from all three regions meet in a global workshop to bring together the regional findings and translate them into implementation‑supportive actions.
Step 5: Global synthesis publication
The combined insights from all regions and the global workshop are synthesised into a final publication on global learnings and actionable recommendations for implementation‑supportive frameworks.
Participants
The study is open to experts with professional experience in health policy, HTA, reimbursement, procurement, clinical practice, pharmacy, regulatory affairs, implementation science, or biosimilars — working in or with the LATAM, Gulf/EMRO, or ASEAN region.
Data protection
Survey responses will be processed in anonymised or de-identified form and analysed at aggregate level.
If follow-up contact is required for a subsequent Delphi round, contact information should be collected separately from survey responses wherever possible. This helps preserve confidentiality while maintaining continuity across rounds.
Organisers
This study is conducted as a project of i-HTScience and I2GG.
i‑HTScience
i‑HTScience is the scientific and methodological platform of EuroScan/i-HTS. It engages members and partner organisations of EuroScan/i-HTS in scientific projects.
I2GG
I2GG is a research institute of applied science for strategic health analysis with a focus on health technology assessment, implementation questions and life‑cycle–oriented evaluation of health technologies. I2GG is member of EuroScan/i-HTS (i2gg.de).
FAQ
Why does this study focus on implementation?
Because the practical uptake of biosimilars is shaped not only by evidence and regulation, but also by organisational, financial, behavioural, and system-level conditions.
Will there be more than one survey round?
Modified Delphi studies commonly include at least two rounds in order to provide feedback and reassessment. The final agreementw will be done within a workshop.
How long will participation take?
Completion time for the first-round survey is expected to be approximately 15 to 20 minutes.
Will responses remain confidential?
Responses will be analysed in anonymised or de-identified and aggregated form, and no individual response will be attributed without explicit consent.